Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 444

Related Citations for PubMed (Select 12734395)

1.

Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.

Füller T, Korff T, Kilian A, Dandekar G, Augustin HG.

J Cell Sci. 2003 Jun 15;116(Pt 12):2461-70. Epub 2003 May 6.

2.

EphB4 signaling is capable of mediating ephrinB2-induced inhibition of cell migration.

Sturz A, Bader B, Thierauch KH, Glienke J.

Biochem Biophys Res Commun. 2004 Jan 2;313(1):80-8.

PMID:
14672701
3.

Distinct roles of ephrin-B2 forward and EphB4 reverse signaling in endothelial cells.

Hamada K, Oike Y, Ito Y, Maekawa H, Miyata K, Shimomura T, Suda T.

Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):190-7.

4.

Endothelial ephrinB2 is controlled by microenvironmental determinants and associates context-dependently with CD31.

Korff T, Dandekar G, Pfaff D, Füller T, Goettsch W, Morawietz H, Schaffner F, Augustin HG.

Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):468-74. Epub 2005 Dec 15.

5.

EphB4 promotes site-specific metastatic tumor cell dissemination by interacting with endothelial cell-expressed ephrinB2.

Héroult M, Schaffner F, Pfaff D, Prahst C, Kirmse R, Kutschera S, Riedel M, Ludwig T, Vajkoczy P, Graeser R, Augustin HG.

Mol Cancer Res. 2010 Oct;8(10):1297-309. doi: 10.1158/1541-7786.MCR-09-0453. Epub 2010 Sep 13.

6.

Shear stress increases expression of the arterial endothelial marker ephrinB2 in murine ES cells via the VEGF-Notch signaling pathways.

Masumura T, Yamamoto K, Shimizu N, Obi S, Ando J.

Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2125-31. doi: 10.1161/ATVBAHA.109.193185. Epub 2009 Oct 1.

7.

EphB4 overexpression in B16 melanoma cells affects arterial-venous patterning in tumor angiogenesis.

Huang X, Yamada Y, Kidoya H, Naito H, Nagahama Y, Kong L, Katoh SY, Li WL, Ueno M, Takakura N.

Cancer Res. 2007 Oct 15;67(20):9800-8.

8.

Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment.

Das A, Shergill U, Thakur L, Sinha S, Urrutia R, Mukhopadhyay D, Shah VH.

Am J Physiol Gastrointest Liver Physiol. 2010 Jun;298(6):G908-15. doi: 10.1152/ajpgi.00510.2009. Epub 2010 Mar 25.

9.

Inhibition of tumor growth and angiogenesis by soluble EphB4.

Martiny-Baron G, Korff T, Schaffner F, Esser N, Eggstein S, Marmé D, Augustin HG.

Neoplasia. 2004 May-Jun;6(3):248-57.

10.

The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade.

Scehnet JS, Ley EJ, Krasnoperov V, Liu R, Manchanda PK, Sjoberg E, Kostecke AP, Gupta S, Kumar SR, Gill PS.

Blood. 2009 Jan 1;113(1):254-63. doi: 10.1182/blood-2008-02-140020. Epub 2008 Oct 3.

11.

Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.

Noren NK, Lu M, Freeman AL, Koolpe M, Pasquale EB.

Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5583-8. Epub 2004 Apr 5.

12.

Stromal cells expressing ephrin-B2 promote the growth and sprouting of ephrin-B2(+) endothelial cells.

Zhang XQ, Takakura N, Oike Y, Inada T, Gale NW, Yancopoulos GD, Suda T.

Blood. 2001 Aug 15;98(4):1028-37.

13.

Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.

Zamora DO, Davies MH, Planck SR, Rosenbaum JT, Powers MR.

Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2175-82.

14.

Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development.

Cowan CA, Yokoyama N, Saxena A, Chumley MJ, Silvany RE, Baker LA, Srivastava D, Henkemeyer M.

Dev Biol. 2004 Jul 15;271(2):263-71.

PMID:
15223333
16.

Soluble form of ephrinB2 inhibits xenograft growth of squamous cell carcinoma of the head and neck.

Kimura M, Kato Y, Sano D, Fujita K, Sakakibara A, Kondo N, Mikami Y, Tsukuda M.

Int J Oncol. 2009 Feb;34(2):321-7.

PMID:
19148465
17.

Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes.

Pfaff D, Héroult M, Riedel M, Reiss Y, Kirmse R, Ludwig T, Korff T, Hecker M, Augustin HG.

J Cell Sci. 2008 Nov 15;121(Pt 22):3842-50. doi: 10.1242/jcs.030627. Epub 2008 Oct 28.

18.

EphB4 controls blood vascular morphogenesis during postnatal angiogenesis.

Erber R, Eichelsbacher U, Powajbo V, Korn T, Djonov V, Lin J, Hammes HP, Grobholz R, Ullrich A, Vajkoczy P.

EMBO J. 2006 Feb 8;25(3):628-41. Epub 2006 Jan 19.

19.

EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells.

Kim I, Ryu YS, Kwak HJ, Ahn SY, Oh JL, Yancopoulos GD, Gale NW, Koh GY.

FASEB J. 2002 Jul;16(9):1126-8. Epub 2002 May 21.

20.

Mesangial cells stimulate differentiation of endothelial cells to form capillary-like networks in a three-dimensional culture system.

Kitahara T, Hiromura K, Ikeuchi H, Yamashita S, Kobayashi S, Kuroiwa T, Kaneko Y, Ueki K, Nojima Y.

Nephrol Dial Transplant. 2005 Jan;20(1):42-9. Epub 2004 Nov 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk